Every source has a job.

01 / Provider offer

Checked 2026-09-26

CoreAge Rx: Spot On ↗

Three named ingredients and $54.99 monthly starting amount; individual strengths, quantity and renewal quote remain to be confirmed.

02 / Provider offer

Checked 2026-09-26

Musely: The Spot Cream ↗

Current two-month auto-refill presentation and self-reported outcomes; no independent trial audit.

03 / Provider formula

Checked 2026-09-26

Musely: Spot Cream formulas ↗

Formula options, initial-fill steroid notes and prescriber discretion. The Nurture list differs from the separate melasma article.

04 / Provider terms

Checked 2026-09-26

Musely: melasma treatment details ↗

$72 two-month auto-refill supply, $20 doctor visit and 60-day consultation period. Provider claims about clinical superiority or pregnancy are not adopted as personalized advice.

05 / Provider terms

Checked 2026-09-26

Musely: 60-Day Result Guarantee ↗

Initial-medication refund conditions and exclusions; not a medical instruction to continue through a reaction.

06 / Provider offer

Checked 2026-09-26

Dermatica: US prescription service ↗

28-day trial with a $4.99 prescribing fee advertised; check the selected US offer and eligibility.

07 / Provider formula

Checked 2026-09-26

Dermatica: melasma treatment ↗

Ingredient options and two-bottle delivery at approximately 56-day intervals; not a fixed formula for every patient.

08 / Provider terms

Checked 2026-09-26

Dermatica: pricing ↗

$29.95 per bottle and $59.90 every two months on the displayed plan; preserve the billing units.

09 / Provider formula

Checked 2026-09-26

Dermatica: ingredients ↗

Hydroquinone 4% listed among available ingredients; actual prescribing remains individual.

10 / Provider offer

Checked 2026-09-26

Skin Medicinals: care pathway ↗

Office evaluation, clinician selection and subsequent patient billing and shipping request.

11 / Provider formula

Checked 2026-09-26

Skin Medicinals: hyperpigmentation ↗

Several hydroquinone strengths and a $48-plus display; not one universal combination or all-in monthly quote.

12 / Provider terms

Checked 2026-09-26

Skin Medicinals: shipping and returns ↗

Policy dated August 18, 2026. Prescription shipping varies by pharmacy; separate retail-shop terms should not be blended with prescription rules.

13 / Regulatory reference

Checked 2026-09-26

FDA: skin product safety ↗

OTC hydroquinone sales, prescription distinction and reported harms; not a quality finding about a named reviewed cream.

14 / Regulatory reference

Checked 2026-09-26

FDA: OTC skin-lightening communication ↗

2022 communication explains the OTC issue and the approval of Tri-Luma; historical date retained.

15 / Regulatory reference

Checked 2026-09-26

FDA: compounded-drug risks ↗

Compounded preparations are not FDA-approved finished drugs. Category context does not prove a particular product has a defect.

16 / Regulatory reference

Checked 2026-09-26

FDA: state-licensed pharmacy lookup ↗

State-board links and consumer checks; this publication has not audited each potential dispenser.

17 / Medical reference

Checked 2026-09-26

AAD: melasma diagnosis and treatment ↗

Diagnosis and individualized care context; not comparative evidence for reviewed providers.

18 / Medical reference

Checked 2026-09-26

AAD: melasma self-care ↗

Sun protection, visible light and irritation considerations within melasma care.

19 / Medical reference

Checked 2026-09-26

AAD: fading dark spots ↗

Underlying causes and pigmentation after inflammation; product-list language is not a diagnosis.

20 / Medical reference

Checked 2026-09-26

AAD: pregnancy skincare ↗

Hydroquinone is listed among ingredients to avoid during pregnancy; individual circumstances need clinical discussion.

21 / Medicine label

Checked 2026-09-26

DailyMed: Tri-Luma label ↗

Defined three-drug product, indication and limits; its label and evidence should not be transferred to other compounded formulas.